These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 15637349)

  • 1. PPARgamma-mediated insulin sensitization: the importance of fat versus muscle.
    Kintscher U; Law RE
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E287-91. PubMed ID: 15637349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance.
    Amin RH; Mathews ST; Camp HS; Ding L; Leff T
    Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E28-37. PubMed ID: 19843873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs.
    Gayet C; Leray V; Saito M; Siliart B; Nguyen P
    Br J Nutr; 2007 Sep; 98(3):497-503. PubMed ID: 17475082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.
    Muise ES; Azzolina B; Kuo DW; El-Sherbeini M; Tan Y; Yuan X; Mu J; Thompson JR; Berger JP; Wong KK
    Mol Pharmacol; 2008 Aug; 74(2):403-12. PubMed ID: 18467542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of action of thiazolidinediones].
    Girard J
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):271-8. PubMed ID: 11452221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
    Kang L; Sebastian BM; Pritchard MT; Pratt BT; Previs SF; Nagy LE
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1581-8. PubMed ID: 17624994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A type IV P-type ATPase affects insulin-mediated glucose uptake in adipose tissue and skeletal muscle in mice.
    Dhar MS; Yuan JS; Elliott SB; Sommardahl C
    J Nutr Biochem; 2006 Dec; 17(12):811-20. PubMed ID: 16517145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
    Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells.
    Chung SS; Kim M; Youn BS; Lee NS; Park JW; Lee IK; Lee YS; Kim JB; Cho YM; Lee HK; Park KS
    Mol Cell Biol; 2009 Jan; 29(1):20-30. PubMed ID: 18936159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?
    Bouskila M; Pajvani UB; Scherer PE
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S17-23. PubMed ID: 15711577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term exercise increases the DNA binding activity of peroxisome proliferator-activated receptor gamma in rat adipose tissue.
    Petridou A; Tsalouhidou S; Tsalis G; Schulz T; Michna H; Mougios V
    Metabolism; 2007 Aug; 56(8):1029-36. PubMed ID: 17618946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding.
    Miles PD; Barak Y; Evans RM; Olefsky JM
    Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E618-26. PubMed ID: 12556354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma: the more the merrier?
    Argmann CA; Cock TA; Auwerx J
    Eur J Clin Invest; 2005 Feb; 35(2):82-92; discussion 80. PubMed ID: 15667578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development.
    Sébert SP; Lecannu G; Kozlowski F; Siliart B; Bard JM; Krempf M; Champ MM
    Int J Obes (Lond); 2005 Mar; 29(3):324-33. PubMed ID: 15672115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
    Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
    Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
    LeBrasseur NK; Kelly M; Tsao TS; Farmer SR; Saha AK; Ruderman NB; Tomas E
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E175-81. PubMed ID: 16464908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.